Iovance Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary

Iovance Biotherapeutics

08/08/2024 22:02

* Iovance Biotherapeutics Inc  IOVA.OQ  reported a quarterly
adjusted loss of 34 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -47 cents.  The mean expectation of
thirteen analysts for the quarter was for a loss of 35 cents per
share. Wall Street expected results to range from -44 cents
to -29 cents per share.
    * Revenue rose 12,969.7% to $31.11 million from a year ago;
analysts expected $24.59 million. 
    * Iovance Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 34 cents​.
    * The company reported a quarterly loss of $97.1 million.
    * Iovance Biotherapeutics Inc shares had fallen by 8.6% this
quarter and lost 9.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Iovance
Biotherapeutics Inc is $25.00 
This summary was machine generated from LSEG data August 8 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.35          -0.34          Beat
 Mar. 31 2024      -0.42          -0.42          Met
 Dec. 31 2023      -0.43          -0.45          Missed
 Sep. 30 2023      -0.45          -0.46          Missed